NCT05365451View on ClinicalTrials.gov

Pharmacokinetic Drug-Drug Interaction Study to Identify Biomarkers of Kidney Transporters

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

April 11, 2022

Primary Completion Date

July 22, 2023

Study Completion Date

July 22, 2023

Conditions
InteractionEndogenous Biomarkers
Interventions
DRUG

MetFORMIN Oral Solution

liquid

DRUG

Cimetidine 400 MG

tablet

DRUG

Furosemide Oral Liquid Product

oral solution

DRUG

Probenecid 500 MG

tablet

Trial Locations (1)

99202

Washington State University College of Pharmacy and Pharmaceutical Sciences, Spokane

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

collaborator

National Institutes of Health (NIH)

NIH

lead

Washington State University

OTHER